Atrial Fibrillation Clinical Trials in Chicago, Illinois

9 studies are recruiting for atrial fibrillation in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

   REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

   Stage

   Phase 3

   Ages

   22 to 85

   Site

   University of Illinois Chicago, Chicago, Illinois

   Locations

   93 in total

   Run by

   Johns Hopkins University

   See if you can join NCT05836987 on ClinicalTrials.gov

2. NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial

   The goal of this clinical trial is to determine if a machine learning/artificial intelligence (AI)-based electrocardiogram (ECG) algorithm (rECHOmmend and ECG-AF) can identify undiagnosed cardiovascular disease in patients. It will also examine the safety and effectiveness of using this AI-based to…

   Stage

   Not phased

   Ages

   40 and older

   Site

   Northwestern University, Chicago, Illinois

   Run by

   Northwestern University

   See if you can join NCT06511505 on ClinicalTrials.gov

3. PULSED AF Post-Approval Study

   PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Endeavor Health Swedish Hospital, Chicago, Illinois

   Locations

   23 in total

   Run by

   Medtronic Cardiac Ablation Solutions

   See if you can join NCT06578104 on ClinicalTrials.gov

4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

   Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Rush University Medical Center, Chicago, Illinois

   Locations

   187 in total

   Run by

   Yale University

   See if you can join NCT03907046 on ClinicalTrials.gov

5. Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone

   The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

   Stage

   EARLY_Phase 1

   Ages

   20 to 85

   Site

   The University of Chicago, Chicago, Illinois

   Run by

   University of Chicago

   See if you can join NCT06063538 on ClinicalTrials.gov

6. Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

   The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard AF treatments.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   University of Chicago, Chicago, Illinois

   Locations

   2 in total

   Run by

   University of Chicago

   See if you can join NCT06499857 on ClinicalTrials.gov

7. Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

   In this pilot and feasibility study, the investigators will enroll patients with frequent symptomatic episodes of atrial fibrillation (AF) in a cross-over study testing two different classes of anti arrhythmic drugs (AADs). This pilot and feasibility study will provide preliminary data for a larger…

   Stage

   Phase 4

   Ages

   18 to 100

   Site

   University of Illinois at Chicago, Chicago, Illinois

   Locations

   4 in total

   Run by

   University of Illinois at Chicago

   See if you can join NCT02347111 on ClinicalTrials.gov

8. CardioFocus HeartLight Post-Approval Study

   This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Illinois, Chicago, Illinois

   Locations

   4 in total

   Run by

   CardioFocus

   See if you can join NCT03168659 on ClinicalTrials.gov

9. MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

   The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. …

   Stage

   Not phased

   Ages

   18 and older

   Site

   CorVita Science Foundation (NFP), Chicago, Illinois

   Run by

   CorVita Science Foundation

   See if you can join NCT05978466 on ClinicalTrials.gov